An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy

Clinical trial NCT00791492 · COMPLETED

Trial details

NCT number: NCT00791492
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Familial Amyloid Polyneuropathy ATTR-PN

Start date: 2008-07-01
Primary completion: 2008-08-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.